Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02965963Completed
Randomised, double-blind trial of dopamine (3 arms), sponsored by University of Alberta. Primary endpoints: Pulmonary Capillary Blood Volume at Day 3, Diffusing Capacity for Carbon Monoxide at Day 3 and 3 more. Started Dec 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02965963.